Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 versus DEXTROSE 5 IN ACETATED RINGER S IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 5 versus DEXTROSE 5 IN ACETATED RINGER S IN PLASTIC CONTAINER.
DEXTROSE 5% vs DEXTROSE 5% IN ACETATED RINGER'S IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose 5% provides a source of calories and water for intravenous administration. It is metabolized to carbon dioxide and water, yielding energy. Dextrose solutions exert osmotic effects and can increase blood glucose levels.
Dextrose is a monosaccharide that provides caloric supplementation and serves as a source of glucose for cellular metabolism. Acetate in Ringer's solution is metabolized to bicarbonate, acting as an alkalinizing agent to correct acidosis. The electrolyte composition (sodium, potassium, calcium, chloride, magnesium, acetate) maintains fluid and electrolyte balance.
Intravenous infusion; 5% dextrose in water (D5W) is typically administered at a rate of 100-200 mL/hour to provide 50-100 g of glucose per day for maintenance hydration and minimal caloric support in adults.
Intravenous infusion, typically 1000-2000 mL per 24 hours, rate adjusted based on fluid and electrolyte needs.
None Documented
None Documented
0.5-1 hour (endogenous glucose); intravenous infusion half-life is variable due to continuous cellular uptake and metabolism; clinical context: rapid clearance via insulin-mediated cellular uptake and glycolysis.
Not applicable; dextrose is rapidly metabolized and cleared; functional half-life of infused fluid is about 15–30 minutes via redistribution and renal excretion.
Renal: 100% (D-glucose and its metabolites, including CO2 and water); less than 1% excreted unchanged in urine under normal conditions; fecal excretion negligible.
Renal: >95% as water; acetate and electrolytes are metabolized or excreted renally.
Category C
Category C
IV Fluid
IV Fluid